| Financial Year |
March 31 2023 |
| Monetary Funds |
726,015,108.80 |
| Held-for-trading Financial Assets |
127,786,893.47 |
| Notes Receivable |
195,603,414.03 |
| Accounts Receivable |
432,860,649.92 |
| Advances to Suppliers |
8,690,842.44 |
| Other Receivables |
309,889,605.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
272,842,935.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,158,561.59 |
| Total Current Assets |
2,092,848,011.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,215,123.60 |
| Investment Properties |
-- |
| Fixed Assetes |
421,606,527.00 |
| Under-construction Projects |
389,865,703.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,825,121.29 |
| R&D expenses |
17,418,088.89 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,786,163.97 |
| Deferred Income Tax Assets |
11,524,878.74 |
| Other Non-Current Assets |
18,907,325.21 |
| Sub-Total of Non-Current Assets |
4,250,634,601.04 |
| Total Assets |
6,343,482,612.18 |
| Short-Term Loans |
439,756,277.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
153,293,555.14 |
| Accounts Payable |
122,124,095.90 |
| Accounts Received In Advance |
402,755.97 |
| Employee Compensation Payable |
6,941,731.81 |
| Taxes Payable |
38,653,652.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,460,573.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
68,957,335.50 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
854,455,976.26 |
| Long-term Loans |
233,780,172.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
8,370,406.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
377,467,982.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
694,488,911.17 |
| Total Liabilities |
1,548,944,887.43 |
| Paid-In Capital(Or Share Stock) |
313,381,402.00 |
| Capital Surplus |
1,481,590,335.07 |
| Surplus Reserve |
116,334,036.38 |
| LESS:Treasury Stock |
149,020,946.26 |
| Undistributed Profits |
857,938,572.85 |
| Minority Stockholder's Interest |
41,570,392.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,752,967,331.99 |
| Owner's Equity（Stockholder's Equity） |
4,794,537,724.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,343,482,612.18 |
